Exane Derivatives’s NVIDIA NVDA Stock Holding History

Exane Derivatives’s Portfolio NVDA Stock Details NVDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$587K	Sell	38,700 -61,530	-61%	-$1.16M	0.34%	67
2022 Q1	$2.73M	Buy	100,230 +3,510	+4%	+$88K	0.77%	19
2021 Q4	$2.84M	Buy	96,720 +5,560	+6%	+$153K	0.69%	21
2021 Q3	$1.89M	Buy	91,160 +12,240	+16%	+$254K	0.45%	41
2021 Q2	$1.6M	Buy	78,920 +25,160	+47%	+$403K	0.36%	57
2021 Q1	$718K	Sell	53,760 -61,040	-53%	-$820K	0.21%	110
2020 Q4	$1.5M	Buy	114,800 +15,960	+16%	+$214K	0.44%	45
2020 Q3	$1.34M	Buy	98,840 +14,800	+18%	+$172K	0.39%	56
2020 Q2	$798K	Sell	84,040 -114,480	-58%	-$926K	0.21%	97
2020 Q1	$1.31M	Buy	+198,520	New	+$1.25M	0.37%	66
2019 Q4	–	Sell	-42,760	Closed	-$186K	–	700
2019 Q3	$186K	Sell	42,760 -89,760	-68%	-$378K	0.03%	264
2019 Q2	$544K	Buy	132,520 +30,040	+29%	+$124K	0.1%	166
2019 Q1	$460K	Buy	+102,480	New	+$398K	0.09%	156
2018 Q4	–	Sell	-44,120	Closed	-$310K	–	720
2018 Q3	$310K	Sell	44,120 -32,360	-42%	-$210K	0.06%	199
2018 Q2	$453K	Buy	76,480 +10,320	+16%	+$62.7K	0.08%	189
2018 Q1	$366K	Buy	66,160 +13,120	+25%	+$77.1K	0.07%	179
2017 Q4	$257K	Buy	53,040 +16,400	+45%	+$81.5K	0.04%	220
2017 Q3	$164K	Buy	+36,640	New	+$152K	0.03%	210
2017 Q1	–	Sell	-29,600	Closed	-$79K	–	629
2016 Q4	$79K	Hold	29,600	–	–	0.02%	261
2016 Q3	$50.7K	Hold	29,600	–	–	0.01%	303
2016 Q2	$34.8K	Sell	29,600 -25,160	-46%	-$25.9K	0.01%	298
2016 Q1	$48.8K	Sell	54,760 -50,560	-48%	-$38.6K	0.01%	313
2015 Q4	$86.8K	Buy	105,320 +105,080	+43,783%	+$79.2K	0.01%	223
2015 Q3	$148	Hold	240	–	–	﹤0.01%	471
2015 Q2	$121	Hold	240	–	–	﹤0.01%	487
2015 Q1	$126	Sell	240 -83,160	-100%	-$44.2K	﹤0.01%	484
2014 Q4	$41.8K	Buy	+83,400	New	+$40.6K	0.01%	340

Other funds holding NVDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Exane Derivatives's NVDA Position: Q2 2022 in Review

Exane Derivatives reduced its NVIDIA (NVDA) stake by 61% in Q2 2022, selling an estimated $1.16M and leaving 38,700 shares worth $587K. The position accounts for 0.34% of the portfolio, ranked #67.

Exane Derivatives first reported a position in NVDA in Q4 2014 and has held it in 27 quarters since. The position peaked at $2.84M in Q4 2021. 2,826 funds tracked by Wall St. Rank hold NVDA as of Q2 2022.

Exane Derivatives held 38,700 shares of NVIDIA worth $587K as of Q2 2022.
Exane Derivatives sold 61,530 NVIDIA shares in Q2 2022, an estimated $1.16M.
NVIDIA made up 0.34% of Exane Derivatives's portfolio in Q2 2022, its #67 holding.
Exane Derivatives first reported a position in NVIDIA in Q4 2014 and has held it in 27 quarters since.
Exane Derivatives's NVIDIA position peaked at $2.84M in Q4 2021.
2,826 funds tracked by Wall St. Rank held NVIDIA as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.